"10.1371_journal.pone.0104763","plos one","2014-08-20T00:00:00Z","Nicoletta Loberto; Maela Tebon; Ilaria Lampronti; Nicola Marchetti; Massimo Aureli; Rosaria Bassi; Maria Grazia Giri; Valentino Bezzerri; Valentina Lovato; Cinzia Cantù; Silvia Munari; Seng H Cheng; Alberto Cavazzini; Roberto Gambari; Sandro Sonnino; Giulio Cabrini; Maria Cristina Dechecchi","Laboratory of Molecular Pathology, Department of Pathology and Diagnostics, University Hospital of Verona, Verona, Italy; Department of Medical Biotechnology and Translational Medicine, University of Milano, Milano, Italy; Department of Life Sciences and Biotechnology, Section of Biochemistry and Molecular Biology, University of Ferrara, Ferrara, Italy; Department of Chemistry and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy; Medical Physics Unit, Department of Pathology and Diagnostics, University Hospital of Verona, Verona, Italy; Genzyme, a Sanofi Company, Framingham, Massachusetts, United States of America","Conceived and designed the experiments: MCD MA SS GC. Performed the experiments: NL MT IL NM RB VB VL CC SM. Analyzed the data: MCD MA NL NM MGG AC RG. Contributed reagents/materials/analysis tools: SHC MGG. Wrote the paper: MCD SHC MA RB NL .","Seng H. Cheng is an employee and shareholder of Genzyme, a Sanofi Company, when the work was performed. This work is also part of a patent application titled “Amorphous and a crystalline form of Genz 112638 hemitartrate as inhibitor of glucosylceramide synthase” (International Application No: PCT/US20130137743A1). However, this does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2014","08","Nicoletta Loberto","NL",17,TRUE,4,9,7,6,TRUE,TRUE,FALSE,0,NA,FALSE
